Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nature Communications|September 7, 2021
Cellular model system to dissect the isoform-selectivity of Akt inhibitorsLena Quambusch, Laura Depta, Ina Landel, et al.
Oncoimmunology|July 7, 2017
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expressionJulian P Layer, Marie T Kronmüller, Thomas Quast, et al.
International Journal of Cancer|July 22, 2014
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating SurvivinKristina Althoff, Sven Lindner, Andrea Odersky, et al.
Cancer Research|May 31, 2018
Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic TargetingPhyllis F Cheung, Florian Neff, Christian Neander, et al.
Oncotarget|October 22, 2016
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cellsKathrin Fielitz, Kristina Althoff, Katleen De Preter, et al.
Oncotarget|December 31, 2016
The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma modelsKristian W Pajtler, Natalie Sadowski, Sandra Ackermann, et al.
Cell Reports|April 6, 2025
PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinomaBen Zhao, Rui Fang, Hendrik Schürmann, et al.
Cancer Letters|July 1, 2015
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastomaAnneleen Beckers, Gert Van Peer, Daniel R Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Targeting MYCN-Driven Transcription By BET-Bromodomain InhibitionAnton Henssen, Kristina Althoff, Andrea Odersky, et al.
Oncogene|December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expressionShana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Pageof 3